PUBLIC COMPANY
save$ADAGAdagene Inc.
$ADAGJiangsu, CNupdated 2mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors
- phase1A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients
- phase2ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- phase2ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors
- phase1ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 4m ago
Found something off?
comments(0)
5-min edit window · permanent after that